GE Yokogawa sees exports hit by rising yen:
This article was originally published in Clinica
GE Yokogawa Medical Systems saw sales rise 6.2% in fiscal 1995 (ended November) to ¥2,000 million ($766 million). Income decreased 5.6% to Yen8,440 million, reports Japan Medical Review. Domestic sales totalled Yen59,400 million, up 9.5% over the previous year, while exports were affected by the appreciating yen, falling 1.5% to Yen22,600 million. GEYMS expects to report sales of Yen99,300 million in fiscal 1996.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.